Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Is vinblastine the same as velban?

See the DrugPatentWatch profile for vinblastine

What is the relationship between vinblastine and Velban?

Vinblastine and Velban are related but not exactly the same thing. Velban is a brand name for vinblastine, a chemotherapy medication used to treat various types of cancer. Vinblastine is the generic or active ingredient in Velban [1]. In other words, Velban is a specific formulation of the medication that is marketed and sold under that brand name, while vinblastine is the generic name for the active ingredient.

History and development

Velban was developed by Eli Lilly and Company, which received a patent for the drug in 1976 [2]. However, the generic name vinblastine has been in use since the 1960s. The patent for Velban expired in 1996, allowing other manufacturers to produce generic versions of the medication.

Are all vinblastine products the same?

While all vinblastine products contain the same active ingredient, they may differ in terms of their formulation, dosage, and administration. Some generic versions of vinblastine may not be bioequivalent to Velban, meaning they may not have the same effect on the body [3].

Patent expiry and competition

The patent expiry of Velban has led to increased competition in the market for vinblastine products. According to DrugPatentWatch.com, there are currently several generic versions of vinblastine available in the United States, including versions from manufacturers such as Sandoz and Teva Pharmaceuticals [4].

References

[1] https://www.drugs.com/velban.html
[2] https://patents.google.com/patent/US3949193
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261444/
[4] https://www.drugpatentwatch.com/drug/vinblastine-velblan-vlbe